skip to content
Skip Navigation
Suven Life Sciences

Drug Discovery & Development Support Services (DDDSS)

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists.

Read More..

Drug Discovery & Research/Clinical pipeline

Suven discovery research is focused on discovering and developing new chemical entities (NCEs), which are best in class central nervous system therapies for the treatment of a diverse range of disorders.

Read More..


  • Suven Life Sciences announces Positive Topline Results from a Phase-2 study evaluating Samelisant
  • Suven Life Sciences Announces Scientific Presentation at CTAD-2023: Study Design of Global Phase-3
  • Suven Life Announces Clinical and Preclinical data Poster Presentations at AAIC 2023, Amsterdam.
  • Suven announces two poster presentations from the phase-2 (PoC) study on samelisant (SUVN-G3031)
  • Suven completed enrollment of patients to the phase-2(PoC) clinical study of SUVN-G3031 in US,CANADA
More >>

Past Events